{
    "clinical_study": {
        "@rank": "107475", 
        "arm_group": [
            {
                "arm_group_label": "Qizhitongluo Capsule", 
                "arm_group_type": "Experimental", 
                "description": "Basic treatment\uff1aAspirin Enteric-coated Tablets was administered orally at a dosage of 100mg/d once per night;the routine recovery training.\nintervention treatment:the Capsules were administered orally, four capsules each time, three times a day after each meal\uff08placebo was taken only after lunch, and Qizhitongluo Capsule was taken after breakfast and supper)for 12 weeks."
            }, 
            {
                "arm_group_label": "Naoxintong Capsule", 
                "arm_group_type": "Active Comparator", 
                "description": "Basic treatment\uff1aAspirin Enteric-coated Tablets was administered orally at a dosage of 100mg/d once per night; the routine recovery training.\nintervention treatment:Naoxintong Capsule was administered orally, four capsules each time, three times a day after each meal for 12 weeks."
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Basic treatment\uff1aAspirin Enteric-coated Tablets was administered orally at a dosage of 100mg/d once per night and the routine recovery training.\nintervention treatment:placebo capsule was administered orally  four capsules each time, three times a day after each meal for 12 weeks."
            }
        ], 
        "brief_summary": {
            "textblock": "This is a 20-week study consisting of a 12-week  multicenter, randomized,double-blind\n      adaptive study to compare efficacy and safety of Qizhitongluo Capsule,Naoxintong Capsule and\n      placebo in the recovery phase of ischemic stroke with qi deficiency and blood stasis\n      syndrome, and a 8-week post-treatment safety follow-up.After 312 patients complete 12 weeks\n      of treatment there will be an interim analysis."
        }, 
        "brief_title": "Efficacy and Safety of Qizhitongluo Capsule in the Recovery Phase of Ischemic Stroke", 
        "condition": "Ischemic Stroke", 
        "condition_browse": {
            "mesh_term": [
                "Ischemia", 
                "Stroke", 
                "Cerebral Infarction"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Age\u226535 years and <80 years;\n\n          -  Diagnosis of ischemic stroke in recovery phase, according to the Chinese guidelines\n             for the diagnosis and treatment of acute ischemic stroke 2010;\n\n          -  Diagnosis of ischemic stroke with qi deficiency and blood stasis syndrome;\n\n          -  The interval from the onset to recruitment was 15-28 days;\n\n          -  FM score <90 or AQ\uff1c93.8 and diagnosis of  aphasia;\n\n          -  Diagnosis of cerebral anterior circulation obstruction;\n\n          -  4\u2264 NIHSS score\uff1c20;\n\n          -  Patient is willing to participate voluntarily and to sign a written patient informed\n             consent.\n\n        Exclusion Criteria:\n\n          -  Evidence of intracranial hemorrhage (ICH) or other cerebral diseases (eg.vascular\n             malformation, tumor, abscess or multiple sclerosis etc.) on  CT or MRI.\n\n          -  Known history of allergy or suspected allergic to the study drugs.\n\n          -  Liver function impairment with the value of ALT or AST over 1.5-fold of normal value.\n\n          -  Renal dysfunction with the value of serum creatinine over 1.5-fold of normal value.\n\n          -  Cerebral embolism caused by cerebral tumor, cerebral trauma, cerebral parasitosis,\n             rheumatic heart disease, coronary heart disease or other cardiac diseases complicated\n             with atrial fibrillation.\n\n          -  Prestroke score on the mRS \u22652.\n\n          -  Space-occupying lesions, CT or MRI revealed midline structure shift; CT revealed that\n             massive cerebral infarction including more than one lobe of brain or over 1/3 of\n             blood-supply area of middle cerebral artery.\n\n          -  Disable patients prescribed by law\uff08blind, deaf, dumb, mental retardation, mental\n             disorders and physical disabilities which due to other causes affect neural function\n             deficient scale).\n\n          -  Hemorrhagic tendency or recent severe or dangerous bleeding in 3 months.\n\n          -  Suspected addicted into alcohol or drug abuse; with severe complications that would\n             make the condition more complicated assessed by the investigator.\n\n          -  Woman with pregnancy, lactation or positive result of pregnancy test, or women who\n             want to be pregnant in recent.\n\n          -  Patient who is participating in other trials or has been participated in other trials\n             in recent 3 months."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "35 Years"
        }, 
        "enrollment": {
            "#text": "624", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 4, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01762163", 
            "org_study_id": "QZTL2013", 
            "secondary_id": "QZTL"
        }, 
        "intervention": [
            {
                "arm_group_label": "Qizhitongluo Capsule", 
                "intervention_name": "Qizhitongluo Capsule", 
                "intervention_type": "Drug", 
                "other_name": "QZTL group"
            }, 
            {
                "arm_group_label": "Naoxintong Capsule", 
                "intervention_name": "Naoxintong Capsule", 
                "intervention_type": "Drug", 
                "other_name": "NXT group"
            }, 
            {
                "arm_group_label": [
                    "Qizhitongluo Capsule", 
                    "Naoxintong Capsule", 
                    "Placebo"
                ], 
                "intervention_name": "Aspirin Enteric-coated Tablets", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": [
                    "Qizhitongluo Capsule", 
                    "Naoxintong Capsule", 
                    "Placebo"
                ], 
                "intervention_name": "the routine recovery training", 
                "intervention_type": "Behavioral"
            }, 
            {
                "arm_group_label": [
                    "Qizhitongluo Capsule", 
                    "Placebo"
                ], 
                "intervention_name": "placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Aspirin"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "Ischemic Stroke,adaptive design, randomized, double-blind", 
        "lastchanged_date": "February 3, 2014", 
        "location": [
            {
                "contact": {
                    "email": "liwuhuang5912@163.com", 
                    "last_name": "Liwu Huang", 
                    "phone": "15878806668"
                }, 
                "contact_backup": {
                    "email": "chenwei8126@126.com", 
                    "last_name": "Wei Chen", 
                    "phone": "13978824543"
                }, 
                "facility": {
                    "address": {
                        "city": "Nanning", 
                        "country": "China", 
                        "state": "Guangxi", 
                        "zip": "530023"
                    }, 
                    "name": "The First Affiliated Hospital of Guangxi University of Chinese Medicine"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "lfliudequan@163.com", 
                    "last_name": "Dequan Liu, Professor", 
                    "phone": "15831686788"
                }, 
                "contact_backup": {
                    "email": "33804261@qq.com", 
                    "last_name": "Jingjing Chang", 
                    "phone": "18031603677"
                }, 
                "facility": {
                    "address": {
                        "city": "Langfang", 
                        "country": "China", 
                        "state": "Hebei"
                    }, 
                    "name": "Langfang TCM Hospital"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "znqznq@163.com", 
                    "last_name": "Xinzhi Wang, Professor", 
                    "phone": "+86-371-66220364"
                }, 
                "contact_backup": {
                    "email": "liyanmei22@163.com", 
                    "last_name": "Yanmei Li", 
                    "phone": "13764564457"
                }, 
                "facility": {
                    "address": {
                        "city": "Zhengzhou", 
                        "country": "China", 
                        "state": "Henan"
                    }, 
                    "name": "the First affiliated Hospital of Henan University of TCM"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "Zhaojianjun8777@163.com", 
                    "last_name": "Jianjun Zhao, associate professor", 
                    "phone": "+86-15948000771"
                }, 
                "contact_backup": {
                    "email": "2573999012@qq.com", 
                    "last_name": "Yue Wang", 
                    "phone": "15844009550"
                }, 
                "facility": {
                    "address": {
                        "city": "Changchun", 
                        "country": "China", 
                        "state": "Jilin"
                    }, 
                    "name": "the affiliated Hospital to Changchun University of Chinese Medicine"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Jing He", 
                    "phone": "15524587532"
                }, 
                "contact_backup": {
                    "last_name": "Xinyi Gu", 
                    "phone": "13478650197"
                }, 
                "facility": {
                    "address": {
                        "city": "Dalian", 
                        "country": "China", 
                        "state": "Liaoning"
                    }, 
                    "name": "Zhongshan Hospital Dalian University"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "liuh2002@hotmail.com", 
                    "last_name": "Hui Liu", 
                    "phone": "18900992700"
                }, 
                "contact_backup": {
                    "email": "41768979@qq.com", 
                    "last_name": "Xia Li"
                }, 
                "facility": {
                    "address": {
                        "city": "Dalian", 
                        "country": "China", 
                        "state": "Liaoning"
                    }, 
                    "name": "201 Hospital of People's Liberation Army"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "inzyjiaofuying@sina.com", 
                    "last_name": "Fuying Jiao, Professor", 
                    "phone": "024-86508813"
                }, 
                "contact_backup": {
                    "email": "yaoliang83730@sina.com", 
                    "last_name": "Liang Yao", 
                    "phone": "15002461511"
                }, 
                "facility": {
                    "address": {
                        "city": "Shenyang", 
                        "country": "China", 
                        "state": "Liaoning"
                    }, 
                    "name": "Second Hospital affiliated to Liaoning University of Traditional Chinese Medicine"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "quyben@163.com", 
                    "last_name": "Yun Qu, associate professor", 
                    "phone": "+86-28-85423523"
                }, 
                "contact_backup": {
                    "email": "58317801@qq.com", 
                    "last_name": "Yi Li", 
                    "phone": "13558660273"
                }, 
                "facility": {
                    "address": {
                        "city": "Chengdu", 
                        "country": "China", 
                        "state": "Sichuan"
                    }, 
                    "name": "West China Hospital,Sichuan University"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "DWTHRC@126.com", 
                    "last_name": "Wentao Ding, associate professor", 
                    "phone": "+86-13261853981"
                }, 
                "contact_backup": {
                    "email": "zhangbo886@sina.com", 
                    "last_name": "Bo Zhang", 
                    "phone": "18612180053"
                }, 
                "facility": {
                    "address": {
                        "city": "Beijing", 
                        "country": "China"
                    }, 
                    "name": "Guang'anmen Hospital Nan District,China Academy of Chinese Medical Sciences"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Yingzhen Xie, Professor", 
                    "phone": "+86-10-84013182"
                }, 
                "contact_backup": {
                    "email": "724277231@qq.com", 
                    "last_name": "Yizhan Wang", 
                    "phone": "18810466346"
                }, 
                "facility": {
                    "address": {
                        "city": "Beijing", 
                        "country": "China", 
                        "zip": "100700"
                    }, 
                    "name": "Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "jy1988mzh@163.com", 
                    "last_name": "Zhihong Meng, Professor", 
                    "phone": "+86-18722699933"
                }, 
                "contact_backup": {
                    "email": "huangdxy@hotmail.com", 
                    "last_name": "Xiaoyu Dai", 
                    "phone": "13012289781"
                }, 
                "facility": {
                    "address": {
                        "city": "Tianjin", 
                        "country": "China"
                    }, 
                    "name": "First Teaching Hospital of Tianjin University of TCM"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_arms": "3", 
        "official_title": "Efficacy and Safety of Qizhitongluo Capsule in the Recovery Phase of Ischemic Stroke With Qi Deficiency and Blood Stasis Syndrome: a Multicenter, Randomized,Double-blind\uff0cPlacebo- and Active-controlled Adaptive Study", 
        "other_outcome": [
            {
                "measure": "The modified Rankin Scale(mRS) score", 
                "safety_issue": "No", 
                "time_frame": "baseline"
            }, 
            {
                "measure": "the National Health Interview Surveys (NHISS) score", 
                "safety_issue": "No", 
                "time_frame": "baseline"
            }
        ], 
        "overall_contact": {
            "email": "zhonw@vip.sina.com", 
            "last_name": "Zhong Wang, Ph.D", 
            "phone": "+86-10-64014411", 
            "phone_ext": "3308"
        }, 
        "overall_contact_backup": {
            "email": "holiwu@yeah.net", 
            "last_name": "Hongli Wu, M.D.", 
            "phone": "+86-10-64014411", 
            "phone_ext": "2802"
        }, 
        "overall_official": [
            {
                "affiliation": "Institute of Basic Research in Clinical Medicine\uff0cChina Academy of Chinese Medical Sciences", 
                "last_name": "Zhong Wang, Ph.D.", 
                "role": "Study Director"
            }, 
            {
                "affiliation": "Dongzhimen Hospital, Beijing", 
                "last_name": "Yingzhen Xie, M.D.", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "China: Food and Drug Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "change in the Lower Extremity Fugl-Meyer score", 
            "safety_issue": "No", 
            "time_frame": "baseline, after 4,12 weeks of treatment, after  90 days of onset."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01762163"
        }, 
        "responsible_party": {
            "investigator_affiliation": "China  Academy of Chinese Medical Sciences", 
            "investigator_full_name": "Zhong Wang", 
            "investigator_title": "Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "Change in Aphasia Quotient\uff08AQ) score", 
                "safety_issue": "No", 
                "time_frame": "baseline, after 4,12 weeks of treatment, after  90 days of onset."
            }, 
            {
                "measure": "Change in Barthel Index score and proportion of subjects with Barthel Index score \u226590", 
                "safety_issue": "No", 
                "time_frame": "baseline, after 4,12 weeks of treatment, after  90 days of onset."
            }, 
            {
                "measure": "Change in the Upper Extremity Fugl-Meyer score", 
                "safety_issue": "No", 
                "time_frame": "baseline, after 4,12 weeks of treatment, after  90 days of onset."
            }, 
            {
                "measure": "Change in the total Fugl-Meyer motor score", 
                "safety_issue": "No", 
                "time_frame": "baseline, after 4,12 weeks of treatment, after  90 days of onset."
            }, 
            {
                "measure": "Change in the syndrome score of Qi Deficiency and Blood Stasis", 
                "safety_issue": "No", 
                "time_frame": "baseline, after 4,12 weeks of treatment, after  90 days of onset."
            }, 
            {
                "measure": "the incidence of New-onset cardiovascular events", 
                "safety_issue": "Yes", 
                "time_frame": "during the 20-weeks"
            }, 
            {
                "measure": "Changes in plasma glucose and lipid concentrations and blood coagulate", 
                "safety_issue": "Yes", 
                "time_frame": "baseline and after 12 weeks of treatment"
            }, 
            {
                "measure": "physical examination\u3001 laboratory tests and ECG", 
                "safety_issue": "Yes", 
                "time_frame": "baseline and  after 12 weeks of treatment"
            }, 
            {
                "measure": "the incidence of adverse events", 
                "safety_issue": "Yes", 
                "time_frame": "during the 20-weeks"
            }, 
            {
                "measure": "all cause mortality", 
                "safety_issue": "Yes", 
                "time_frame": "during the 20-weeks"
            }
        ], 
        "source": "China  Academy of Chinese Medical Sciences", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "China  Academy of Chinese Medical Sciences", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}